Chondrocytes from patients with osteoarthritis express typical extracellular matrix molecules once grown onto a three-dimensional hyaluronan-based scaffold

Journal of Biomedical Materials Research - Part A

Volumn 93, Issue 1, 2010, Pages 86-95

  Cavallo, Carola ^a   Desando, Giovanna ^a   Facchini, Andrea ^a,b   Grigolo, Brunella ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Chondrocytes; Hyaluronan; Immunohistochemistry; Molecular biology; Osteoarthritis

Indexed keywords

AUTOLOGOUS CHONDROCYTE TRANSPLANTATIONS; CELL TYPES; CHONDROCYTES; CLINICAL PRACTICES; COLLAGEN TYPE I; EXPERIMENTAL CULTURES; EXTRACELLULAR MATRIX MOLECULES; GROWTH FACTOR; HYALURONAN; IMMUNOHISTOCHEMISTRY; MOLECULAR LEVELS; PROTEIN LEVEL; REAL-TIME PCR; TYPE II;

BIOCHEMISTRY; CARTILAGE; CELL CULTURE; COLLAGEN; GENE EXPRESSION; LIGAMENTS; MOLECULAR BIOLOGY; MOLECULAR STRUCTURE; MOLECULES; MONOLAYERS; SCAFFOLDS; TISSUE ENGINEERING;

BODY FLUIDS;

AGGRECAN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; HYALURONIC ACID; SCLEROPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR SOX9;

ADULT; AGED; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; OSTEOARTHRITIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE ENGINEERING;

ADULT; AGED; BIOCOMPATIBLE MATERIALS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SURVIVAL; CHONDROCYTES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; KINETICS; MALE; MIDDLE AGED; OSTEOARTHRITIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE SCAFFOLDS;

EID: 77649227934     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32547     Document Type: Article

References (44)

1. Scott JC, Lethbridge-Cejku M, Hochberg MC. Epidemiology and economic consequences of osteoarthritis. In: Reginster JY, Pelletier JP, Martel-Pelletier J, Henrotin Y, editors. Osteoarthritis. Clinical and Experimental Aspects. Berlin: Springer; 1999. p 20-52.
2. Mapel DW, Shainline M, Paez K, Gunter M. Hospital, pharmacy, and outpatient costs for osteoarthritis and chronic back pain. J Rheumatol 2004;31:573-583.
3. Rosemann T, Laux G, Szecsenyi J. Osteoarthritis: Quality of life, comorbidities, medication and health service utilization assessed in a large sample of primary care patients. J Orthop Surg 2007;30:2-12.
4. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D, van den Berg WB. Osteoarthritis cartilage histopathology: Grading and staging. Osteoarthritis Cartilage 2006;14:13-29.
5. Lorenz H, Richter W. Osteoarthritis: Cellular and molecular changes in degenerating cartilage. Prog Histochem Cytochem 2006;40:135-163.
6. Hashimoto M, Nakasa T, Hikata T, Asahara H. Molecular network of cartilage homeostasis and osteoarthritis. Med Res Rev 2008;28:464-481.
7. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol 2007;213:626-634.
8. Goldring MB. Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Best Pract Res Clin Rheumatol 2006;20:1003-1025.
9. Poole AR. Cartilage in health and disease. In: Koopman W, editor. Arthritis and Allied Conditions: A Textbook of Rheumatology, 14th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p 226-284.
10. Aigner T, Soeder S, Haag J. IL-1β and BMPs-Interactive players of cartilage matrix degradation and regeneration. Eur Cell Mater 2006;12:49-56.
11. Goldring SR, Goldring MB. The role of cytochines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 2004;427(Suppl):S27-S36.
12. Goldring MB, Goldring SR. Osteoarthritis and cartilage: The role of cytokines. Curr Rheumatol Rep 2000;2:459-465.
13. Martel-Pelletier J, Alaaeddine N, Pelletier JP. Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci 1999;4:d694-d703.
14. Silvestri T, Meliconi R, Pulsatelli L, Dolzani P, Zizzi F, Frizziero L, Borzì RM, Facchini A. Down-modulation of chemokine receptor cartilage expression in inflammatory arthritis. Rheumatology 2003;42:14-18.
15. Martel-Pelletier J. Pathophysiology of osteoarthritis. Osteoarthritis Cart 2004;12(Suppl A):S31-S33.
16. Wegman A, van der Windt D, van Tulder M, Stalman W, de Vries T. Nonsteroidal antiinflammatory drugs or acetaminophen for osteoarthritis of the hip or knee? A systematic review of evidence and guidelines. J Rheumatol 2004;31:344-354.
17. Fenton C, Keating GM, Wagstaff AJ. Valdecoxib: A review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain. Drugs 2004;64:1231-1261.
18. McHugh GA, Campbell M, Silman AJ, Kay PR, Luker KA. Patients waiting for a hip or knee joint replacement: Is there any prioritization for surgery? J Eval Clin Pract 2008;14:361-367.
19. Porcheret M, Jordan K, Jinks C, Croft P; Primary Care Rheumatology Society. Primary care treatment of knee pain-A survey in older adults. Rheumatology (Oxford) 2007;46:1694-1700.
20. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994;331:889-895.
21. Jones DG, Peterson L. Autologous chondrocyte implantation. Instr Course Lect 2007;56:429-445.
22. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007;213:341-347.
23. Peterson L, Brittberg M, Kiviranta I, Akerlund EL, Lindahl A. Autologous chondrocyte transplantation. Biomechanics and long-term durability. Am J Sports Med 2002;30:2-12.
24. Briggs TW, Mahroof S, David LA, Flannelly J, Pringle J, Bayliss M. Histological evaluation of chondral defects after autologous chondrocyte implantation of the knee. J Bone Joint Surg Br 2003;85:1077-1083.
25. Knutsen G, Drogset JO, Engebretsen L, Grøntvedt T, Isaksen V, Ludvigsen TC, Roberts S, Solheim E, Strand T, Johansen O. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am 2008;90:1165-1166.
26. Grigolo B, De Franceschi L, Roseti L, Cattini L, Facchini A. Down regulation of degenerative cartilage molecules in chondrocytes grown on a hyaluronan-based scaffold. Biomaterials 2005;26:5668-5676.
27. Marcacci M, Berruto M, Brocchetta D, Delcogliano A, Ghinelli D, Gobbi A, Kon E, Pederzini L, Rosa D, Sacchetti GL, Stefani G, Zanasi S. Articular cartilage engineering with Hyalograft C: 3-year clinical results. Clin Orthop Relat Res 2005;435:96-105.
28. Pavesio A, Abatangelo G, Borrione A, Brocchetta D, Hollander AP, Kon E, Torasso F, Zanasi S, Marcacci M. Hyaluronan-based scaffolds (Hyalografts C) in the treatment of knee cartilage defects: Preliminary clinical findings. Novartis Found Symposium 2003;249:203-217; discussion 229-233, 234-238, 239-241.
29. Marcacci M, Zaffagnini S, Kon E, Visani A, Iacono F, Loreti L. Arthroscopic autologous chondrocyte transplantation: Technical note. Knee Surg Sports Traumatol Arthrosc 2002;10:154-159.
30. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957;16:494-502.
31. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039-1049.
32. Grigolo B, Roseti L, Neri S, Gobbi P, Jensen P, Major EO, Facchini A. Human articular chondrocytes immortalized by HPV-16 E6 and E7 genes: Maintenance of differentiated phenotype under defined culture conditions. Osteoarthritis Cartilage 2002;10:879-889.
33. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modification to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;22:271-277.
34. Martin I, Jakob M, Schäfer D, Dick W, Spagnoli G, Heberer M. Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. Ostearthritis Cartilage 2001;9:112-118.
35. Grigolo B, Roseti L, Fiorini M, Piacentini A, De Franceschi L, Facchini A. Cathepsin B as a soluble marker to monitor the phenotypic stability of engineered cartilage. Biomaterials 2003;24:1751-1757.
36. Blanco FJ, Geng Y, Lotz M. Differentiation-dependent effects of IL-1 and TGF-β on human articular chondrocyte proliferation are related to inducible nitric oxide synthase expression. J Immunol 1995;154:4018-4026.
37. Grigolo B, Lisignoli G, Piacentini A, Fiorini M, Gobbi P, Mazzotti G, Duca M, Pavesio A, Facchini A. Evidence for redifferentiation of human chondrocytes grown on a hyaluronanbased biomaterial-based biomaterial (HYAFF®11): Molecular, immunohistochemical and ultrastructural analysis. Biomaterials 2002;23/4:1187-1195.
38. Rousseau JC, Delmas PD. Biological markers in osteoarthritis. Nat Clin Pract Rheumatol 2007;6:346-356.
39. Quasnichka HL, Anderson-MacKenzie JM, Bailey AJ. Subchondral bone and ligament changes precede cartilage degradation in guinea pig osteoarthritis. Biorheology 2006;43:389-397.
40. Mankin HJ. Current concepts review: The response of articular cartilage to mechanical injury. J Bone Joint Surg (Am) 1982;64:460-466.
41. Wang CT, Lin J, Chang CJ, Lin YT, Hou SM. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee: A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004;86A:538-545.
42. Emans PJ, Pieper J, Hulsbosch MM, Koenders M, Kreijveld E, Surtel DA, van Blitterswijk CA, Bulstra SK, Kuijer R, Riesle J. Differential cell viability of chondrocytes and progenitor cells in tissue-engineered constructs following implantation into osteochondral defects. Tissue Eng 2006;12:1699-1709.
43. Nehrer S, Domayer S, Dorotka R, Schatz K, Bindreiter U, Kotz R. Three-year clinical outcome after chondrocyte transplantation using a hyaluronan matrix for cartilage repair. Eur J Radiol 2006;57:3-8.
44. Tallheden T, Bengtsson C, Brantsing C, Sjögren-Jansson E, Carlsson L, Peterson L, Brittberg M, Lindahl A. Proliferation and differentiation potential of chondrocytes from osteoarthritic patients. Arthritis Res Ther 2005;7:R560-R568.